
Venkataraman Balasubramanian
Examiner (ID: 17374, Phone: (571)272-0662 , Office: P/1624 )
Most Active Art Unit | 1624 |
Art Unit(s) | 1624, 1611 |
Total Applications | 2999 |
Issued Applications | 2017 |
Pending Applications | 254 |
Abandoned Applications | 728 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 6248859
[patent_doc_number] => 20100137269
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-03
[patent_title] => 'Novel C-17-Heteroaryl Steroidal Cyp17 Inhibitors/Antiandrogens: Synehesis, In Vitro Biological Activities, Pharmacokinetics and Antitumor Activity'
[patent_app_type] => utility
[patent_app_number] => 12/623257
[patent_app_country] => US
[patent_app_date] => 2009-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 14026
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20100137269.pdf
[firstpage_image] =>[orig_patent_app_number] => 12623257
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/623257 | Novel C-17-Heteroaryl Steroidal Cyp17 Inhibitors/Antiandrogens: Synehesis, In Vitro Biological Activities, Pharmacokinetics and Antitumor Activity | Nov 19, 2009 | Abandoned |
Array
(
[id] => 7762451
[patent_doc_number] => 08114862
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-02-14
[patent_title] => 'TGR5 modulators and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 12/622123
[patent_app_country] => US
[patent_app_date] => 2009-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 91
[patent_no_of_words] => 47543
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/114/08114862.pdf
[firstpage_image] =>[orig_patent_app_number] => 12622123
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/622123 | TGR5 modulators and methods of use thereof | Nov 18, 2009 | Issued |
Array
(
[id] => 7501621
[patent_doc_number] => 20110263555
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-27
[patent_title] => 'TGR5 Modulators and Methods of Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 13/129947
[patent_app_country] => US
[patent_app_date] => 2009-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 17378
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0263/20110263555.pdf
[firstpage_image] =>[orig_patent_app_number] => 13129947
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/129947 | TGR5 modulators and methods of use thereof | Nov 18, 2009 | Issued |
Array
(
[id] => 6295419
[patent_doc_number] => 20100160263
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-24
[patent_title] => '7,9-SUBSTITUTED TETRACYCLINE COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 12/617111
[patent_app_country] => US
[patent_app_date] => 2009-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10132
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20100160263.pdf
[firstpage_image] =>[orig_patent_app_number] => 12617111
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/617111 | 7,9-SUBSTITUTED TETRACYCLINE COMPOUNDS | Nov 11, 2009 | Abandoned |
Array
(
[id] => 6450742
[patent_doc_number] => 20100145083
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-10
[patent_title] => 'PREPARATION OF BILE ACIDS AND INTERMEDIATES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/613969
[patent_app_country] => US
[patent_app_date] => 2009-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8117
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0145/20100145083.pdf
[firstpage_image] =>[orig_patent_app_number] => 12613969
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/613969 | Preparation of bile acids and intermediates thereof | Nov 5, 2009 | Issued |
Array
(
[id] => 7685408
[patent_doc_number] => 20100120733
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-13
[patent_title] => 'STEROID MODULATORS OF GLUCOCORTICOID RECEPTOR'
[patent_app_type] => utility
[patent_app_number] => 12/613628
[patent_app_country] => US
[patent_app_date] => 2009-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11331
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0120/20100120733.pdf
[firstpage_image] =>[orig_patent_app_number] => 12613628
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/613628 | STEROID MODULATORS OF GLUCOCORTICOID RECEPTOR | Nov 5, 2009 | Abandoned |
Array
(
[id] => 7586337
[patent_doc_number] => 20110280847
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-17
[patent_title] => 'METHODS AND COMPOSITIONS FOR INHIBITING CLOSTRIDIUM DIFFICILE SPORE GERMINATION AND OUTGROWTH'
[patent_app_type] => utility
[patent_app_number] => 13/126687
[patent_app_country] => US
[patent_app_date] => 2009-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 20497
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0280/20110280847.pdf
[firstpage_image] =>[orig_patent_app_number] => 13126687
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/126687 | Methods and compositions for inhibiting clostridium difficile spore germination and outgrowth | Nov 1, 2009 | Issued |
Array
(
[id] => 6455287
[patent_doc_number] => 20100105700
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-29
[patent_title] => 'DECAHYDRO-1H-INDENOQUINOLINONE AND DECAHYDRO-3H-CYCLOPENTAPHENANTHRIDINONE CYP17 INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/603377
[patent_app_country] => US
[patent_app_date] => 2009-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 76590
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20100105700.pdf
[firstpage_image] =>[orig_patent_app_number] => 12603377
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/603377 | DECAHYDRO-1H-INDENOQUINOLINONE AND DECAHYDRO-3H-CYCLOPENTAPHENANTHRIDINONE CYP17 INHIBITORS | Oct 20, 2009 | Abandoned |
Array
(
[id] => 7680652
[patent_doc_number] => 20100105934
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-29
[patent_title] => 'FULVESTRANT INTERMEDIATE'
[patent_app_type] => utility
[patent_app_number] => 12/579478
[patent_app_country] => US
[patent_app_date] => 2009-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8018
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20100105934.pdf
[firstpage_image] =>[orig_patent_app_number] => 12579478
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/579478 | FULVESTRANT INTERMEDIATE | Oct 14, 2009 | Abandoned |
Array
(
[id] => 6466699
[patent_doc_number] => 20100040568
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-18
[patent_title] => 'Steroidal compounds as melanogenesis modifiers and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/587882
[patent_app_country] => US
[patent_app_date] => 2009-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 30589
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20100040568.pdf
[firstpage_image] =>[orig_patent_app_number] => 12587882
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/587882 | Steroidal compounds as melanogenesis modifiers and uses thereof | Oct 12, 2009 | Abandoned |
Array
(
[id] => 6594696
[patent_doc_number] => 20100048524
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-25
[patent_title] => 'Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens;Synthesis In Vitro Biological Activities, Pharmacokinetics and Antitumor Activity'
[patent_app_type] => utility
[patent_app_number] => 12/577092
[patent_app_country] => US
[patent_app_date] => 2009-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14030
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20100048524.pdf
[firstpage_image] =>[orig_patent_app_number] => 12577092
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/577092 | Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens;Synthesis In Vitro Biological Activities, Pharmacokinetics and Antitumor Activity | Oct 8, 2009 | Abandoned |
Array
(
[id] => 6602279
[patent_doc_number] => 20100048913
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-25
[patent_title] => 'Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens;Synthesis In Vitro Biological Activities, Pharmacokinetics and Antitumor Activity'
[patent_app_type] => utility
[patent_app_number] => 12/577094
[patent_app_country] => US
[patent_app_date] => 2009-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14033
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20100048913.pdf
[firstpage_image] =>[orig_patent_app_number] => 12577094
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/577094 | Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens;Synthesis In Vitro Biological Activities, Pharmacokinetics and Antitumor Activity | Oct 8, 2009 | Abandoned |
Array
(
[id] => 6578321
[patent_doc_number] => 20100047338
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-25
[patent_title] => 'Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens, In Vitro Biological Activities, Pharmacokinetics and Antitumor Activity'
[patent_app_type] => utility
[patent_app_number] => 12/577090
[patent_app_country] => US
[patent_app_date] => 2009-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14032
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0047/20100047338.pdf
[firstpage_image] =>[orig_patent_app_number] => 12577090
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/577090 | Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens, In Vitro Biological Activities, Pharmacokinetics and Antitumor Activity | Oct 8, 2009 | Abandoned |
Array
(
[id] => 6602264
[patent_doc_number] => 20100048912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-25
[patent_title] => 'Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens, In Vitro Biological Activities, Pharmacokinetics and Antitumor Activity'
[patent_app_type] => utility
[patent_app_number] => 12/577091
[patent_app_country] => US
[patent_app_date] => 2009-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14031
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20100048912.pdf
[firstpage_image] =>[orig_patent_app_number] => 12577091
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/577091 | Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens, In Vitro Biological Activities, Pharmacokinetics and Antitumor Activity | Oct 8, 2009 | Abandoned |
Array
(
[id] => 6602294
[patent_doc_number] => 20100048914
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-25
[patent_title] => 'Novel C-17-Heteroaryl Steroidal Cyp17 Inhibitors/Antiandrogens, In Vitro Biological Activities, Pharmacokinetics and Antitumor Activity'
[patent_app_type] => utility
[patent_app_number] => 12/577096
[patent_app_country] => US
[patent_app_date] => 2009-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14031
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20100048914.pdf
[firstpage_image] =>[orig_patent_app_number] => 12577096
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/577096 | Novel C-17-Heteroaryl Steroidal Cyp17 Inhibitors/Antiandrogens, In Vitro Biological Activities, Pharmacokinetics and Antitumor Activity | Oct 8, 2009 | Abandoned |
Array
(
[id] => 6189974
[patent_doc_number] => 20110172258
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2011-07-14
[patent_title] => 'INDENE DERIVATIVES AS PHARMACEUTICAL AGENTS'
[patent_app_type] => utility
[patent_app_number] => 12/564747
[patent_app_country] => US
[patent_app_date] => 2009-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 59912
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A9/0172/20110172258.pdf
[firstpage_image] =>[orig_patent_app_number] => 12564747
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/564747 | Indene derivatives as pharmaceutical agents | Sep 21, 2009 | Issued |
Array
(
[id] => 6189974
[patent_doc_number] => 20110172258
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2011-07-14
[patent_title] => 'INDENE DERIVATIVES AS PHARMACEUTICAL AGENTS'
[patent_app_type] => utility
[patent_app_number] => 12/564747
[patent_app_country] => US
[patent_app_date] => 2009-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 59912
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A9/0172/20110172258.pdf
[firstpage_image] =>[orig_patent_app_number] => 12564747
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/564747 | Indene derivatives as pharmaceutical agents | Sep 21, 2009 | Issued |
Array
(
[id] => 7696039
[patent_doc_number] => 20110230551
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-22
[patent_title] => 'WITHAFERIN A ANALOGS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/063825
[patent_app_country] => US
[patent_app_date] => 2009-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 25667
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0230/20110230551.pdf
[firstpage_image] =>[orig_patent_app_number] => 13063825
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/063825 | WITHAFERIN A ANALOGS AND USES THEREOF | Sep 14, 2009 | Abandoned |
Array
(
[id] => 6603581
[patent_doc_number] => 20100063019
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-11
[patent_title] => 'Low Dose Estrogen Interrupted Hormone Replacement Therapy'
[patent_app_type] => utility
[patent_app_number] => 12/555196
[patent_app_country] => US
[patent_app_date] => 2009-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5926
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20100063019.pdf
[firstpage_image] =>[orig_patent_app_number] => 12555196
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/555196 | Low Dose Estrogen Interrupted Hormone Replacement Therapy | Sep 7, 2009 | Abandoned |
Array
(
[id] => 7540424
[patent_doc_number] => 08058267
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-15
[patent_title] => 'Steroids as agonists for FXR'
[patent_app_type] => utility
[patent_app_number] => 12/547147
[patent_app_country] => US
[patent_app_date] => 2009-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4825
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/058/08058267.pdf
[firstpage_image] =>[orig_patent_app_number] => 12547147
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/547147 | Steroids as agonists for FXR | Aug 24, 2009 | Issued |